Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Marcia Meseck"'
Autor:
Satish Rojekar, Anusha R Pallapati, Judit Gimenez-Roig, Funda Korkmaz, Farhath Sultana, Damini Sant, Clement M Haeck, Anne Macdonald, Se-Min Kim, Clifford J Rosen, Orly Barak, Marcia Meseck, John Caminis, Daria Lizneva, Tony Yuen, Mone Zaidi
Publikováno v:
eLife, Vol 12 (2023)
Highly concentrated antibody formulations are oftentimes required for subcutaneous, self-administered biologics. Here, we report the development of a unique formulation for our first-in-class FSH-blocking humanized antibody, MS-Hu6, which we propose
Externí odkaz:
https://doaj.org/article/dbfcd21d71574f6ca1d659719f942a73
Autor:
Sakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, Funda Korkmaz, Damini Sant, Victoria DeMambro, Karthyayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, Abraham Teunissen, Mandy MT van Leent, Tomas GJM Post, Jessica C Fernandes, Jessica Netto, Farhath Sultana, Eleanor Shelly, Satish Rojekar, Pushkar Kumar, Liam Cullen, Jiya Chatterjee, Anusha Pallapati, Sari Miyashita, Hasni Kannangara, Megha Bhongade, Puja Sengupta, Kseniia Ievleva, Valeriia Muradova, Rogerio Batista, Cemre Robinson, Anne Macdonald, Susan Hutchison, Mansi Saxena, Marcia Meseck, John Caminis, Jameel Iqbal, Maria I New, Vitaly Ryu, Se-Min Kim, Jay J Cao, Neeha Zaidi, Zahi A Fayad, Daria Lizneva, Clifford J Rosen, Tony Yuen, Mone Zaidi
Publikováno v:
eLife, Vol 11 (2022)
Pharmacological and genetic studies over the past decade have established the follicle-stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely osteoporosis, obesity, and Alzheimer’s disease. Blocking FSH action pre
Externí odkaz:
https://doaj.org/article/0b0425ac3b2842fcad3a4a75380448c1
Autor:
Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn, Piengthong Narakorn, Somchaiya Surichan, Sumalee Prangpratanporn, Suttida Puksuriwong, Steven Lamola, Laina D. Mercer, Rama Raghunandan, Weina Sun, Yonghong Liu, Juan Manuel Carreño, Rami Scharf, Weerapong Phumratanaprapin, Fatima Amanat, Luc Gagnon, Ching-Lin Hsieh, Ruangchai Kaweepornpoj, Sarwat Khan, Manjari Lal, Stephen McCroskery, Jason McLellan, Ignacio Mena, Marcia Meseck, Benjaluck Phonrat, Yupa Sabmee, Ratsamikorn Singchareon, Stefan Slamanig, Nava Suthepakul, Johnstone Tcheou, Narumon Thantamnu, Sompone Theerasurakarn, Steven Tran, Thanakrit Vilasmongkolchai, Jessica A White, Nina Bhardwaj, Adolfo Garcia-Sastre, Peter Palese, Florian Krammer, Kittisak Poopipatpol, Ponthip Wirachwong, Richard Hjorth, Bruce L Innis
Publikováno v:
EClinicalMedicine, Vol 45, Iss , Pp 101323- (2022)
Summary: Background: Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based recombinant Newcastle disease virus vaccine expressing the spike (S) prote
Externí odkaz:
https://doaj.org/article/ffb4f5b1dc304f6186c8f2d2d34e14cf
Autor:
Nina Bhardwaj, Marshall Posner, Philip Friedlander, John Mandeli, Sacha Gnjatic, Eric Schadt, Samir Parekh, Julia Kodysh, Alex Rubinsteyn, John Finnigan, Ana Blazquez, Mansi Saxena, Marcia Meseck, Daniela Delbeau, Matthew Galsky, Deborah Doroshow, Brett Miles, Krysztof Misiukiewicz, Hanna Irie, Amy Tiersten, Andrea Wolf, Jeffrey Hammerbacher, Michael Donovan, Rachel Brody
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/2fdb09ee544e42f79751e40542a845ff
Autor:
Damini Sant, Satish Rojekar, Sakshi Gera, Anusha R. Pallapati, Judit Gimenez‐Roig, Tan‐Chun Kuo, Ashley Padilla, Funda Korkmaz, Liam Cullen, Jiya Chatterjee, Eleanor Shelly, Marcia Meseck, Sari Miyashita, Anne Macdonald, Farhath Sultana, Orly Barak, Vitaly Ryu, Se‐Min Kim, Cemre Robinson, Clifford J. Rosen, John Caminis, Daria Lizneva, Shozeb Haider, Tony Yuen, Mone Zaidi
Publikováno v:
Annals of the New York Academy of Sciences. 1521:67-78
Autor:
Nina Bhardwaj, Rachel Lubong Sabado, Sacha Gnjatic, Sreekumar Balan, Gustavo Gimenez, Christopher B. McClain, Andres M. Salazar, John Mandeli, Rose Marie Holman, Thomas U. Marron, Patrick A. Ott, Michael Lattanzi, Marcia Meseck, Ana B. Blazquez, Anna Pavlick
Overlapping peptides covering the entire NY-ESO-1 protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c627173eb2706be395627a622e3335
https://doi.org/10.1158/2326-6066.22543318
https://doi.org/10.1158/2326-6066.22543318
Autor:
Nina Bhardwaj, Rachel Lubong Sabado, Sacha Gnjatic, Sreekumar Balan, Gustavo Gimenez, Christopher B. McClain, Andres M. Salazar, John Mandeli, Rose Marie Holman, Thomas U. Marron, Patrick A. Ott, Michael Lattanzi, Marcia Meseck, Ana B. Blazquez, Anna Pavlick
Descriptions of Supplementary Figures 1, 2, and 3, and supplementary table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b5728b6953f614c7e0a9320cbfea71
https://doi.org/10.1158/2326-6066.22543321.v1
https://doi.org/10.1158/2326-6066.22543321.v1
Autor:
Nina Bhardwaj, Rachel Lubong Sabado, Sacha Gnjatic, Sreekumar Balan, Gustavo Gimenez, Christopher B. McClain, Andres M. Salazar, John Mandeli, Rose Marie Holman, Thomas U. Marron, Patrick A. Ott, Michael Lattanzi, Marcia Meseck, Ana B. Blazquez, Anna Pavlick
Supplementary Fig 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613dfae31ff045cf7f097fd9b820dd3d
https://doi.org/10.1158/2326-6066.22543330
https://doi.org/10.1158/2326-6066.22543330
Autor:
Nina Bhardwaj, Rachel Lubong Sabado, Sacha Gnjatic, Sreekumar Balan, Gustavo Gimenez, Christopher B. McClain, Andres M. Salazar, John Mandeli, Rose Marie Holman, Thomas U. Marron, Patrick A. Ott, Michael Lattanzi, Marcia Meseck, Ana B. Blazquez, Anna Pavlick
Supplementary Fig 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7680f3d77c52e52f04f20bd56c5e6de7
https://doi.org/10.1158/2326-6066.22543333.v1
https://doi.org/10.1158/2326-6066.22543333.v1
Autor:
Nina Bhardwaj, Rachel Lubong Sabado, Sacha Gnjatic, Sreekumar Balan, Gustavo Gimenez, Christopher B. McClain, Andres M. Salazar, John Mandeli, Rose Marie Holman, Thomas U. Marron, Patrick A. Ott, Michael Lattanzi, Marcia Meseck, Ana B. Blazquez, Anna Pavlick
Given its ability to induce both humoral and cellular immune responses, NY-ESO-1 has been considered a suitable antigen for a cancer vaccine. Despite promising results from early-phase clinical studies in patients with melanoma, NY-ESO-1 vaccine immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c85972d6d0007ff4430fc95692a12e
https://doi.org/10.1158/2326-6066.c.6550219.v1
https://doi.org/10.1158/2326-6066.c.6550219.v1